esophageal squamous carcinoma
Recently Published Documents


TOTAL DOCUMENTS

154
(FIVE YEARS 44)

H-INDEX

20
(FIVE YEARS 3)

2021 ◽  
Vol 116 (1) ◽  
pp. S211-S211
Author(s):  
Chenyu Sun ◽  
Yuting Huang ◽  
Sudha Misra ◽  
John Pocholo W. Tuason ◽  
Na Hyun Kim ◽  
...  

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Huiyu Yang ◽  
Jie Wang ◽  
Suliman Khan ◽  
Yuanying Zhang ◽  
Kuicheng Zhu ◽  
...  

2021 ◽  
Vol 11 (9) ◽  
pp. 1844-1847
Author(s):  
DaoBin Lin ◽  
Zhangkai Yang ◽  
YiHua Su ◽  
YaWei Cheng

Carvacrol is a natural phenol with antioxidant, antimicrobials, and anti-cancer activities. The present study aimed to explore the anti-cancer activity of carvacrol in human esophageal squamous carcinoma KYSE-150 cells. Cell proliferation and apoptosis were measured using WST-1 assay and cell death detection ELISA kit respectively. Caspase activities were determined with caspase fluorometric assay kits. WST-1 assay revealed that carvacrol suppressed KYSE-150 cell proliferation in both dose and time-dependent manner. Carvacrol could increase cell apoptosis in a dose-dependent manner through caspase-3 and caspase-9 activation. In addition, Bcl-2 mRNA levels were significantly decreased by carvacrol treatment. This study delivers that carvacrol exerts a favorable anti-cancer action against esophageal cancer via inhibiting cell proliferation and inducing cell apoptosis. These discoveries suggest that carvacrol is deserved to be further studied and developed as a chemotherapeutic agent for esophageal cancer.


2021 ◽  
Author(s):  
Zhong Wu ◽  
Jin Zhou ◽  
Xiaoyang Zhang ◽  
Zhouwei Zhang ◽  
Yingtian Xie ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document